In line with France’s strategy for reindustrialisation, Bioprox Cultures has recently invested several tens of millions of euros to meet the global demand for lactic ferments. Bioprox, a subsidiary of the French family-owned group Proxis Développement, announces a significant investment aimed at modernising and expanding its production facility in Maine-et-Loire. By implementing new high-tech fermentation processes and extending its freeze-drying capacity, the overall productivity of the site is expected to increase by more than 65%. This new momentum further solidifies Bioprox's position in the international market. After several months of work, Bioprox is now finalising this investment, with the new plant set to be operational in 2025. As a recipient of French government’s plan so-called France Relance through its "ModernBio" project, Bioprox is set to create up to 60 new jobs over the next three years, further boosting the economic vitality of the Pays de la Loire region. By significantly increasing its production volumes, Bioprox Cultures continues to pursue its primary goal: enhancing competitiveness and driving innovation within its range of ferments, while providing top-quality service to support its clients.